Short and Long-Term Effectiveness of Existing Insomnia Therapies for Patients Undergoing Hemodialysis

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 126 participants.

Also called NCT03534284

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; triple masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 126 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT03534284
Other papers using this trial's data
  • Effectiveness of Existing Insomnia Therapies for Patients Undergoing Hemodialysis : A Randomized Clinical Trial Annals of internal medicine, 2024-02 DOI, PubMed 38224591

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
United States (from the registry)
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT03534284. Randomized; triple masking; primary purpose treatment. Start 2018-09-19 (actual); primary completion 2022-10-17 (actual). Results posted on 2024-02-05.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Short and Long-Term Effectiveness of Existing Insomnia Therapies for Patients Undergoing Hemodialysis
Acronym
Sleep-HD
Condition
Insomnia
Condition
End Stage Renal Disease
Intervention (Behavioral)
Cognitive Behavioral Therapy for Insomnia
Intervention (Drug)
Trazodone
Intervention (Drug)
Placebo
Lead sponsor
University of Washington (class: other)
Collaborator
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) (class: US National Institutes of Health)

Record details

Record id
cardio:ct-nct03534284
Content hash
562ca9aa768a7b1a3124db0da617996105d9ca6bc818a5de9a696ab439160f11